UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Homozygous E387K (1159G>A) mutation of the CYP1B1 gene in a Roma boy affected with primary congenital glaucoma. Case report

Orvosi hetilap, 2014-08, Vol.155 (33), p.1325

2014

Volltextzugriff (PDF)

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial

JAMA ophthalmology, 2021-01, Vol.139 (1), p.68

2021

Volltextzugriff (PDF)

Effizienter, flexibler und genauer entwurf von mehrlagen-mikrowellenschaltungen mittels modularer techniken

Vogt, Gabor

2017

Volltextzugriff (PDF)

Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes

British journal of ophthalmology, 2023-03, Vol.107 (3), p.384

2023

Volltextzugriff (PDF)

Birth Characteristics of Different Ocular Congenital Abnormalities in Hungary

Ophthalmic epidemiology, 2006-06, Vol.13 (3), p.159-166

2006

Volltextzugriff (PDF)

Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study

Advances in therapy, 2020-04, Vol.37 (4), p.1436-1451

2020

Volltextzugriff (PDF)

Maternal Demographic and Socioeconomic Characteristics of Live-Born Infants With Isolated Ocular Congenital Abnormalities

Ophthalmic epidemiology, 2008-01, Vol.15 (4), p.257-263

2008

Volltextzugriff (PDF)

Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study

Advances in therapy, 2020-08, Vol.37 (8), p.3643-3644

2020

Volltextzugriff (PDF)

Population-based case-control study of isolated congenital cataract

Birth defects research. A Clinical and molecular teratology, 2005-12, Vol.73 (12), p.997-1005

2005

Volltextzugriff (PDF)

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

The Lancet (British edition), 2022-02, Vol.399 (10326), p.729-740

2022

Volltextzugriff (PDF)

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

The Lancet (British edition), 2022-02, Vol.399 (10326), p.741-755

2022

Volltextzugriff (PDF)

A Population-Based Case-Control Study of Isolated Anophthalmia and Microphthalmia

European journal of epidemiology, 2005-11, Vol.20 (11), p.939-946

2005

Volltextzugriff (PDF)

A population-based case-control study of isolated primary congenital glaucoma

American journal of medical genetics. Part A, 2006-06, Vol.140A (11), p.1148-1155

2006

Volltextzugriff (PDF)

On-Orbit Verification of a 4 × 4 Switch Matrix for Space Applications based on the Low Temperature Co-fired Ceramics Technology

Frequenz, 2012-12, Vol.66 (11-12), p.355-362

2012

Volltextzugriff (PDF)

Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment

Advances in therapy, 2022-08, Vol.39 (8), p.3501-3521

2022

Volltextzugriff (PDF)

Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

Ophthalmology (Rochester, Minn.), 2024-06, Vol.131 (6), p.708

2024

Volltextzugriff (PDF)

TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

Ophthalmology (Rochester, Minn.), 2024-08, Vol.131 (8), p.914

2024

Volltextzugriff (PDF)

Population-based case-control study of isolated congenital cataract

Birth defects research. A Clinical and molecular teratology, 2005-12, Vol.73 (12), p.997-1005

2005

Volltextzugriff (PDF)

TENAYA and LUCERNE

Ophthalmology (Rochester, Minn.), 2024-08, Vol.131 (8), p.914-926

2024

Volltextzugriff (PDF)

Faricimab Treat-and-Extend for Diabetic Macular Edema

Ophthalmology (Rochester, Minn.), 2024-06, Vol.131 (6), p.708-723

2024

Volltextzugriff (PDF)

Correction to: Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment

Advances in therapy, 2022-08, Vol.39 (8), p.3522-3523

2022

Volltextzugriff (PDF)

A Population-Based Case-Control Study of Isolated Ocular Coloboma

Ophthalmic epidemiology, 2005-06, Vol.12 (3), p.191-197

2005

Volltextzugriff (PDF)

A population-based case-control study of isolated congenital cataract

Orvosi hetilap, 2006-06, Vol.147 (23), p.1077

2006

Volltextzugriff (PDF)

Material adaptation and optimisation of passive Ka-band multilayer circuit designs using an efficient modular design strategy

The 5th European Microwave Integrated Circuits Conference, 2010, p.385-388

2010

Volltextzugriff (PDF)

Reconfigurable ka-band switch matrix for on-orbit verification

2009 European Microwave Conference (EuMC), 2009, p.610-613

2009

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Humans
(25)
Life Sciences & Biomedicine
(23)
Female
(21)
Male
(19)
Adult
(11)
Middle Aged
(9)
Ophthalmology
(9)
Aged
(8)
Case-Control Studies
(7)
Hungary - Epidemiology
(7)
Biological And Medical Sciences
(5)
Infant, Newborn
(5)
Intravitreal Injections
(5)
Treatment Outcome
(5)
Vascular Endothelial Growth Factor A
(5)
Aged, 80 And Over
(4)
Angiopoietin-2
(4)
Cardiology
(4)
Case-Control Study
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Homozygous E387K (1159G>A) mutation of the CYP1B1 gene in a Roma boy affected with primary congenital glaucoma. Case report

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial

Effizienter, flexibler und genauer entwurf von mehrlagen-mikrowellenschaltungen mittels modularer techniken

Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes

Birth Characteristics of Different Ocular Congenital Abnormalities in Hungary

Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study

Maternal Demographic and Socioeconomic Characteristics of Live-Born Infants With Isolated Ocular Congenital Abnormalities

Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study

Population-based case-control study of isolated congenital cataract

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

A Population-Based Case-Control Study of Isolated Anophthalmia and Microphthalmia

A population-based case-control study of isolated primary congenital glaucoma

On-Orbit Verification of a 4 × 4 Switch Matrix for Space Applications based on the Low Temperature Co-fired Ceramics Technology

Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment

Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

Population-based case-control study of isolated congenital cataract

TENAYA and LUCERNE

Faricimab Treat-and-Extend for Diabetic Macular Edema

Correction to: Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment

A Population-Based Case-Control Study of Isolated Ocular Coloboma

A population-based case-control study of isolated congenital cataract

Material adaptation and optimisation of passive Ka-band multilayer circuit designs using an efficient modular design strategy

Reconfigurable ka-band switch matrix for on-orbit verification

Suchergebnisse filtern